Last updated 20 months ago

tDCS in Post-Acute COVID-19 Patients With SARDs

20 patients around the world

Available in Brazil

Currently, there are no studies evaluating the tDCS technique in ARD patients with post-acute COVID-19; therefore, the main objective of the present study is to evaluate the safety and efficacy of the application of acute tDCS in these specific patients.

University of Sao Paulo

20Patients around the world

Requirements for the patient

To 80 Years

All Gender

Medical requirements

: Patients with well-defined ARDs (rheumatoid arthritis, sclerosis systemic, Sjögren syndrome, spondyloarthritis, systemic lupus erythematosus, systemic vasculitis, and systemic autoimmune myopathies)
Fatigue or general pains.

: Neoplasia, using heart pacemarker, using visceral metalic clips, infections (HIV, HTLV-1, hepatitis), pregnance, previous historical of convulsions or epilepsies

SponsorUniversity of Sao Paulo

Study typeInterventional

Requirements

To 80 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT04890483